Professional Development of Statisticians in Pharmaceutical Research and Development:Some Considerat

来源 :中国上海第七届国际新药发明科技年会 | 被引量 : 0次 | 上传用户:wanglijun123456789
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  In the last 10-15 years,after an implementation of the ICH-E9 guideline entitled "Statistical Principles for Clinical Trials",there has been an increasing awareness of values of statistical contributions to a broader range of drug development process (not only for clinical trials,but for pharmaceutical research and development in general).Then the role,responsibility and carrier opportunities of statisticians involved in the process have been considerably extended.So far most statisticians have learned the principles and techniques in designing and managing clinical trials or planning development strategy of a new drug from an experience with rather less formal training.These have highlighted the need for formal professional development of statisticians.In this presentation,a key area of focus is the education of statisticians and their transition from university into working in the pharmaceutical related field and the preparation for the next generation of statisticians for our brightest future.
其他文献
会议
会议
会议
会议
会议
会议
会议
Human organic anion transporter hOAT1 plays a critical role in the body disposition of clinically important drugs.To investigate the role of transmembrane segment (TM) 12 in the function of hOAT 1,we
会议
2-(5,6-Dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid (DMXAA,ASA404; 1) is a Tumour Vascular Disrupting Agent (Tumour-VDA),in Phase Ⅲ clinical trials for the treatment of non-small cell lung cancer.We rep
会议
Mucoadhesive temperature-mediated in situ gel formulations using chitosan and HPMC were used to enhance intranasal delivery of the dopamine D2 agonist ropinirole to the brain.In vivo bioavailability a
会议